Haupt Pharma’s site in Toride, Japan was successfully inspected at the end of October by Ibaraki prefecture, the local authority, without any significant observation being issued. The inspection covered all GMP areas and was conducted for the renewal of a manufacturing licence. “Particularly against the background of the earthquake disaster in March of this year, the result of the inspection underlines the expertise and commitment of the site’s team, which contributed to this very good result,”...